The Changes of Flavonoids in Honey During Storage
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Metabolic Engineering of Microbial Cell Factories for Biosynthesis of Flavonoids: a Review
molecules Review Metabolic Engineering of Microbial Cell Factories for Biosynthesis of Flavonoids: A Review Hanghang Lou 1,†, Lifei Hu 2,†, Hongyun Lu 1, Tianyu Wei 1 and Qihe Chen 1,* 1 Department of Food Science and Nutrition, Zhejiang University, Hangzhou 310058, China; [email protected] (H.L.); [email protected] (H.L.); [email protected] (T.W.) 2 Hubei Key Lab of Quality and Safety of Traditional Chinese Medicine & Health Food, Huangshi 435100, China; [email protected] * Correspondence: [email protected]; Tel.: +86-0571-8698-4316 † These authors are equally to this manuscript. Abstract: Flavonoids belong to a class of plant secondary metabolites that have a polyphenol structure. Flavonoids show extensive biological activity, such as antioxidative, anti-inflammatory, anti-mutagenic, anti-cancer, and antibacterial properties, so they are widely used in the food, phar- maceutical, and nutraceutical industries. However, traditional sources of flavonoids are no longer sufficient to meet current demands. In recent years, with the clarification of the biosynthetic pathway of flavonoids and the development of synthetic biology, it has become possible to use synthetic metabolic engineering methods with microorganisms as hosts to produce flavonoids. This article mainly reviews the biosynthetic pathways of flavonoids and the development of microbial expression systems for the production of flavonoids in order to provide a useful reference for further research on synthetic metabolic engineering of flavonoids. Meanwhile, the application of co-culture systems in the biosynthesis of flavonoids is emphasized in this review. Citation: Lou, H.; Hu, L.; Lu, H.; Wei, Keywords: flavonoids; metabolic engineering; co-culture system; biosynthesis; microbial cell factories T.; Chen, Q. -
Interpreting Sources and Endocrine Active Components of Trace Organic Contaminant Mixtures in Minnesota Lakes
INTERPRETING SOURCES AND ENDOCRINE ACTIVE COMPONENTS OF TRACE ORGANIC CONTAMINANT MIXTURES IN MINNESOTA LAKES by Meaghan E. Guyader © Copyright by Meaghan E. Guyader, 2018 All Rights Reserved A thesis submitted to the Faculty and the Board of Trustees of the Colorado School of Mines in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Civil and Environmental Engineering). Golden, Colorado Date _____________________________ Signed: _____________________________ Meaghan E. Guyader Signed: _____________________________ Dr. Christopher P. Higgins Thesis Advisor Golden, Colorado Date _____________________________ Signed: _____________________________ Dr. Terri S. Hogue Professor and Department Head Department of Civil and Environmental Engineering ii ABSTRACT On-site wastewater treatment systems (OWTSs) are a suspected source of widespread trace organic contaminant (TOrC) occurrence in Minnesota lakes. TOrCs are a diverse set of synthetic and natural chemicals regularly used as cleaning agents, personal care products, medicinal substances, herbicides and pesticides, and foods or flavorings. Wastewater streams are known to concentrate TOrC discharges to the environment, particularly accumulating these chemicals at outfalls from centralized wastewater treatment plants. Fish inhabiting these effluent dominated environments are also known to display intersex qualities. Concurrent evidence of this phenomenon, known as endocrine disruption, in Minnesota lake fish drives hypotheses that OWTSs, the primary form of wastewater treatment in shoreline residences, may contribute to TOrC occurrence and the endocrine activity in these water bodies. The causative agents specific to fish in this region remain poorly understood. The objective of this dissertation was to investigate OWTSs as sources of TOrCs in Minnesota lakes, and TOrCs as potential causative agents for endocrine disruption in resident fish. -
Combinatorial Biosynthesis of Non-Bacterial and Unnatural Flavonoids, Stilbenoids and Curcuminoids by Microorganisms Sueharu Horinouchi
J. Antibiot. 61(12): 709–728, 2008 THE JOURNAL OF REVIEW ARTICLE ANTIBIOTICS Combinatorial Biosynthesis of Non-bacterial and Unnatural Flavonoids, Stilbenoids and Curcuminoids by Microorganisms Sueharu Horinouchi Received: August 1, 2008 / Accepted: October 14, 2008 © Japan Antibiotics Research Association Abstract One of the approaches of combinatorial biosynthesis is combining genes from different organisms and designing a new set of gene clusters to produce bioactive compounds, leading to diversification of both chemical and natural product libraries. This makes efficient use of the potential of the host organisms, especially when microorganisms are used. An Escherichia coli system, in which artificial biosynthetic pathways for production of plant-specific medicinal polyketides, such as flavonoids, stilbenoids, isoflavonoids, and curcuminoids, are assembled, has been designed and expressed. Starting with amino acids tyrosine and phenylalanine as substrates, this system yields naringenin, resveratrol, genistein, and curcumin, for example, all of which are beneficial to human health because of their wide variety of biological activities. Supplementation of unnatural carboxylic acids to the recombinant E. coli cells carrying the artificial pathways by precursor-directed biosynthesis results in production of unnatural compounds. Addition of decorating or modification enzymes to the artificial pathway leads to production of natural and unnatural flavonols, flavones, and methylated resveratrols. This microbial system is promising for construction of larger libraries by employing other polyketide synthases and decorating enzymes of various origins. In addition, the concept of building and expressing artificial biosynthetic pathways for production of non-bacterial and unnatural compounds in microorganisms should be successfully applied to production of not only plant-specific polyketides but also many other useful compound classes. -
Development and Optimization of a High Sensitivity LC-MS/MS Method for the Determination of Hesperidin and Naringenin in Rat Plasma: Pharmacokinetic Approach
molecules Article Development and Optimization of a High Sensitivity LC-MS/MS Method for the Determination of Hesperidin and Naringenin in Rat Plasma: Pharmacokinetic Approach Jesús Alfredo Araujo-León 1,* , Rolffy Ortiz-Andrade 2, Rivelino Armando Vera-Sánchez 1, Julio Enrique Oney-Montalvo 1, Tania Isolina Coral-Martínez 1 and Zulema Cantillo-Ciau 3 1 Chromatography Laboratory, Chemistry Faculty, Autonomous University of Yucatan, Mérida 97069, Mexico; [email protected] (R.A.V.-S.); [email protected] (J.E.O.-M.); [email protected] (T.I.C.-M.) 2 Pharmacology Laboratory, Chemistry Faculty, Autonomous University of Yucatan, Mérida 97069, Mexico; rolff[email protected] 3 Medicinal Chemistry Laboratory, Chemistry Faculty, Autonomous University of Yucatan, Mérida 97069, Mexico; [email protected] * Correspondence: [email protected]; Tel.: +52-999-922-5708 Academic Editor: Derek J. McPhee Received: 6 August 2020; Accepted: 12 September 2020; Published: 16 September 2020 Abstract: The purpose of this study was to develop, optimize, and fully validate a high-sensitivity methodology using UHPLC-MS/MS to simultaneously quantify hesperidin and naringenin in microsamples (100 µL) of murine plasma after intragastric administration of single pure flavonoids and a mixture. The optimization process allowed for high sensitivity with detection limits of approximately picogram order using an electrospray ionization (ESI) source in negative mode and an experiment based on multiple reaction monitoring (MRM). The validation parameters showed excellent linearity and detection limits, with a precision of less than 8% and a recovery of over 90%. This methodology was applied to compare the pharmacokinetic parameters for the administration of hesperidin and naringenin in individual form or in the form of a mixture. -
Cushnie TPT, Lamb AJ. Antimicrobial Activity of Flavonoids. International Journal of Antimicrobial Agents, 2005. 26(5):343-356
Cushnie TPT, Lamb AJ. Antimicrobial activity of flavonoids. International Journal of Antimicrobial Agents, 2005. 26(5):343-356. PMID: 16323269 DOI: 10.1016/j.ijantimicag.2005.09.002 The journal article above is freely available from the publishers at: http://www.idpublications.com/journals/PDFs/IJAA/ANTAGE_MostCited_1.pdf and also... http://www.ijaaonline.com/article/S0924-8579(05)00255-4/fulltext Errata for the article (typesetting errors by Elsevier Ireland) are freely available from the publishers at: http://www.ijaaonline.com/article/S0924-8579(05)00352-3/fulltext and also... http://www.sciencedirect.com/science/article/pii/S0924857905003523 International Journal of Antimicrobial Agents 26 (2005) 343–356 Review Antimicrobial activity of flavonoids T.P. Tim Cushnie, Andrew J. Lamb ∗ School of Pharmacy, The Robert Gordon University, Schoolhill, Aberdeen AB10 1FR, UK Abstract Flavonoids are ubiquitous in photosynthesising cells and are commonly found in fruit, vegetables, nuts, seeds, stems, flowers, tea, wine, propolis and honey. For centuries, preparations containing these compounds as the principal physiologically active constituents have been used to treat human diseases. Increasingly, this class of natural products is becoming the subject of anti-infective research, and many groups have isolated and identified the structures of flavonoids possessing antifungal, antiviral and antibacterial activity. Moreover, several groups have demonstrated synergy between active flavonoids as well as between flavonoids and existing chemotherapeutics. Reports of activity in the field of antibacterial flavonoid research are widely conflicting, probably owing to inter- and intra-assay variation in susceptibility testing. However, several high-quality investigations have examined the relationship between flavonoid structure and antibacterial activity and these are in close agreement. -
Nominators Pharmacy Compounding
Fagron North America, IACP, NCPA: Nominators Pharmacy Compounding Advisory Committee review of Chrysin June 23, 2016 Chrysin • Naturally occurring bioflavonoid and polyphenolic compound • Found in passion flower indian trumpet flower, honeycomb, chamomile and oyster mushrooms Chrysin • Bioflavonoids such as chrysin can act as chemical messengers • Necessary in the production of plant pigmentations • Involved in UV filtration • Influence the symbiotic relationships of nitrogen fixation Chrysin • FDA has stated that it is a small molecule, can be characterized easily, and is relatively stable under ordinary storage conditions • Chrysin actually has a molecular size of 254.2375 g/mol • Molecular weight consistent with that of steroid hormones Oral supplement dosing • Because of low bioavailability oral dosing is typically referenced at 400 mg – 3 g Br J Clin Pharmacol. 2001 Feb; 51(2): 143–146. Disposition and metabolism of the flavonoid chrysin in normal volunteers T Walle, Y Otake, J A Brubaker, U K Walle, and P V Halushka Conculsion Even though the systemic availability of chrysin appears to be low, this does not exclude the occurrence of local biological effects of the flavonoid, particularly in the intestine. In summary, this study supports the view that the bioavailability of chrysin, and possibly other flavonoids, in humans is very low, due to extensive presystemic intestinal as well as hepatic glucuronidation… Topical administration feasibility • It has been shown in the study of trans dermal drug delivery systems that one of the main criteria for feasibility of drug delivery through the skin is small molecular size of 500 Daltons or less • Other references states that unionized entities have better absorption. -
Simultaneous Determination of Two Galangin Metabolites from Alpinia Officinarum Hance in Rat Plasma by UF LC-MS/MS and Its Application in Pharmacokinetics Study
Simultaneous determination of two galangin metabolites from Alpinia Officinarum Hance in rat plasma by UF LC-MS/MS and its application in pharmacokinetics study Rangru Liu1,2,3, Hailong Li1,2, Na Wei1,2 and Yinfeng Tan1,2 1 Hainan Provincial Key Laboratory of R&D of Tropical Herbs, School of Pharmacy, Hainan Medical University, Haikou, China 2 Haikou Key Laboratory of Li Nationality Medicine, School of Pharmacy, Hainan Medical University, Haikou, China 3 Key Laboratory of Tropical Diseases and Translational Medicine of the Ministry of Education, Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical University, Haikou, Hainan, China ABSTRACT Galangin has multiple pharmacological efficacies, such as anti-cancer, anti- inflammation and anti-oxidation. Galangin can be rapidly converted into glu- curonidated metabolites in vivo. This study aimed to establish an UFLC-MS/MS ana- lytical method to simultaneously determine the concentrations of two glucuronidated metabolites of galangin, galangin-3-O-β-D-glucuronic acid (GG-1) and galangin-7- O-β-D-glucuronic acid (GG-2) in rat plasma. After oral administration of galangal extract (0.3 g/kg), blood samples were collected from the orbital sinus, then treated by methanol precipitation and further gradient-eluted with Phenomenex Kinetex 2.6 mm XB-C18 column. The mass spectrometer was manipulated in the negative electrospray ionization (ESI) and selected multiple reaction monitoring (MRM) mode for the analytes. The precursor-to-product ion pairs applied for GG-1, GG-2 and chrysin (as the internal standard, IS) were m/z 445.2!269.0, 445.2!268.9 and 253.0!142.9, Submitted 29 September 2020 respectively. -
Expression and Functional Analysis of the Nobiletin Biosynthesis-Related
www.nature.com/scientificreports OPEN Expression and functional analysis of the nobiletin biosynthesis‑related gene CitOMT in citrus fruit Mao Seoka1,4, Gang Ma1,2,4, Lancui Zhang2, Masaki Yahata1,2, Kazuki Yamawaki1,2, Toshiyuki Kan3 & Masaya Kato1,2* Nobiletin, a polymethoxy favone (PMF), is specifc to citrus and has been reported to exhibit important health-supporting properties. Nobiletin has six methoxy groups at the 3′,4′,5,6,7,8-positions, which are catalyzed by O-methyltransferases (OMTs). To date, researches on OMTs in citrus fruit are still limited. In the present study, a novel OMT gene (CitOMT) was isolated from two citrus varieties Satsuma mandarin (Citrus unshiu Marc.) and Ponkan mandarin (Citrus reticulata Blanco), and its function was characterized in vitro. The results showed that the expression of CitOMT in the favedo of Ponkan mandarin was much higher than that of Satsuma mandarin during maturation, which was consistent with the higher accumulation of nobiletin in Ponkan mandarin. In addition, functional analysis showed that the recombinant protein of CitOMT had methylation activity to transfer a methyl group to 3′-hydroxy group of favones in vitro. Because methylation at the 3′-position of favones is vital for the nobiletin biosynthesis, CitOMT may be a key gene responsible for nobiletin biosynthesis in citrus fruit. The results presented in this study will provide new strategies to enhance nobiletin accumulation and improve the nutritional qualities of citrus fruit. Flavonoids are a group of secondary metabolites that include more than 10,000 kinds of derivatives1. According to their structure, favonoids are divided into several subgroups, including favanones, favones, favonols, favanols, isofavones, and anthocyanidins2. -
HPLC-DAD-ESI-QTOF-MS Determination of Bioactive Compounds and Antioxidant Activity Comparison of the Hydroalcoholic and Water Ex
H OH metabolites OH Article HPLC-DAD-ESI-QTOF-MS Determination of Bioactive Compounds and Antioxidant Activity Comparison of the Hydroalcoholic and Water Extracts from Two Helichrysum italicum Species Katja Kramberger 1,2 , Darja Barliˇc-Maganja 1, Dunja Bandelj 3, Alenka Baruca Arbeiter 3, Kelly Peeters 4,5, Ana MiklavˇciˇcVišnjevec 3,* and Zala Jenko Pražnikar 1,* 1 Faculty of Health Sciences, University of Primorska, 6310 Izola, Slovenia; [email protected] (K.K.); [email protected] (D.B.-M.) 2 Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia 3 Faculty of Mathematics, Natural Sciences and Information Technologies, University of Primorska, 6000 Koper, Slovenia; [email protected] (D.B.); [email protected] (A.B.A.) 4 InnoRenew CoE, 6310 Izola, Slovenia; [email protected] 5 Andrej MarušiˇcInstitute, University of Primorska, 6000 Koper, Slovenia * Correspondence: [email protected] (A.M.V.); [email protected] (Z.J.P.); Tel.: +386-05-662-6469 (Z.J.P.) Received: 4 September 2020; Accepted: 8 October 2020; Published: 12 October 2020 Abstract: Mediterranean plant Helichrysum italicum represents a rich source of versatile bioactive compounds with potential benefits for human health. Despite extensive research on the plant’s active constituents, little attention has yet been paid to characterizing the relationship between its intra-specific genetic diversity and metabolite profile. The study aimed to determine metabolic profile of H. italicum ssp. italicum (HII) and ssp. tyrrhenicum (HIT) cultivated on the experimental plantation in Slovenia and to compare the chemical composition of extracts regarding the solvent extraction process. Extracts were prepared upon conventional extract preparation procedures: maceration with 50 % methanol or ethanol and cold or hot water infusion and analyzed using High Performance Liquid Chromatography-Diode Array Detection-Electrospray Ionization-Quadrupole Time-of-Flight-Mass Spectrometry (HPLC-DAD-ESI-QTOF-MS). -
Analysis of the Binding and Interaction Patterns of 100 Flavonoids with the Pneumococcal Virulent Protein Pneumolysin: an in Silico Virtual Screening Approach
Available online a t www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (16):40-51 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4 Analysis of the binding and interaction patterns of 100 flavonoids with the Pneumococcal virulent protein pneumolysin: An in silico virtual screening approach Udhaya Lavinya B., Manisha P., Sangeetha N., Premkumar N., Asha Devi S., Gunaseelan D. and Sabina E. P.* 1School of Biosciences and Technology, VIT University, Vellore - 632014, Tamilnadu, India 2Department of Computer Science, College of Computer Science & Information Systems, JAZAN University, JAZAN-82822-6694, Kingdom of Saudi Arabia. _____________________________________________________________________________________________ ABSTRACT Pneumococcal infection is one of the major causes of morbidity and mortality among children below 2 years of age in under-developed countries. Current study involves the screening and identification of potent inhibitors of the pneumococcal virulence factor pneumolysin. About 100 flavonoids were chosen from scientific literature and docked with pnuemolysin (PDB Id.: 4QQA) using Patch Dockprogram for molecular docking. The results obtained were analysed and the docked structures visualized using LigPlus software. It was found that flavonoids amurensin, diosmin, robinin, rutin, sophoroflavonoloside, spiraeoside and icariin had hydrogen bond interactions with the receptor protein pneumolysin (4QQA). Among others, robinin had the highest score (7710) revealing that it had the best geometrical fit to the receptor molecule forming 12 hydrogen bonds ranging from 0.8-3.3 Å. Keywords : Pneumococci, pneumolysin, flavonoids, antimicrobial, virtual screening _____________________________________________________________________________________________ INTRODUCTION Streptococcus pneumoniae is a gram positive pathogenic bacterium causing opportunistic infections that may be life-threating[1]. Pneumococcus is the causative agent of pneumonia and is the most common agent causing meningitis. -
Assembly of a Novel Biosynthetic Pathway for Production of the Plant Flavonoid Fisetin in Escherichia Coli
Downloaded from orbit.dtu.dk on: Oct 06, 2021 Assembly of a novel biosynthetic pathway for production of the plant flavonoid fisetin in Escherichia coli Stahlhut, Steen Gustav; Siedler, Solvej; Malla, Sailesh; Harrison, Scott James; Maury, Jerome; Neves, Ana Rute; Förster, Jochen Published in: Metabolic Engineering Link to article, DOI: 10.1016/j.ymben.2015.07.002 Publication date: 2015 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Stahlhut, S. G., Siedler, S., Malla, S., Harrison, S. J., Maury, J., Neves, A. R., & Förster, J. (2015). Assembly of a novel biosynthetic pathway for production of the plant flavonoid fisetin in Escherichia coli. Metabolic Engineering, 31, 84-93. https://doi.org/10.1016/j.ymben.2015.07.002 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Metabolic Engineering 31 (2015) 84–93 Contents lists available at ScienceDirect Metabolic Engineering journal homepage: www.elsevier.com/locate/ymben Assembly of a novel biosynthetic pathway for production of the plant flavonoid fisetin in Escherichia coli Steen G. -
FDA Briefing Document Pharmacy Compounding Advisory Committee
FDA Briefing Document Pharmacy Compounding Advisory Committee (PCAC) Meeting June 23, 2016 The attached package contains background information prepared by the Food and Drug Administration (FDA) for the panel members of the Pharmacy Compounding Advisory Committee (advisory committee). We are bringing certain compounding issues to this advisory committee to obtain the committee’s advice. The background package may not include all issues relevant to the final regulatory recommendation and instead is intended to focus on issues identified by the Agency for discussion by the advisory committee. The FDA background package often contains assessments and/or conclusions and recommendations written by individual FDA reviewers. Such conclusions and recommendations do not necessarily represent the final position of the individual reviewers, nor do they necessarily represent the final position of the Review Division or Office. The FDA does not intend to issue a final determination on the issues at hand until input from the advisory committee process has been considered, all reviews have been finalized, consultation with the United States Pharmacopeia has occurred, and public comment has been considered through notice and comment rulemaking. The final determination may be affected by issues not discussed at the advisory committee meeting. Table of Contents I. Introduction ................................................................................................................... 3 A. Bulk Drug Substances That Can Be Used by Compounders under